Mars has pledged to invest €1bn into its European operations by the end of 2026 as demand for packaged foods slows in the US and the group seeks EU approval for its $35.9bn acquisition of Pop-Tarts ...

Brendan Carr, the Trump-appointed chair of the Federal Communications Commission, said at a Politico conference this week: “I think you can draw a pretty clear line, and the Supreme Court has done ...

Syria’s President Ahmed al-Sharaa has said negotiations between his country and Israel on a new security agreement could yield results “in the coming days”. His comments come days ahead of his visit ...

BCG consultants working on social impact projects in future must complete “third-party training on humanitarian principles and receive tailored briefings on context and project guardrails”, according ...

European countries including Germany, Switzerland and Austria have this year sent delegations to Afghanistan or welcomed Taliban officials on to their territory to facilitate repatriations. In the UK, ...

In his toast to King Charles at last night’s state banquet, Donald Trump heaped praise on the monarch, the British empire and the ties between the UK and the US. But it seems likely that Starmer will ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Hyundai has upheld its $26bn investment pledge in the US in the wake of a large-scale immigration raid on its ...

Health technology, from stents to CAT scanners, was historically exempt from import duties for ethical reasons ...

The Federal Reserve has cut interest rates for the first time this year, reducing borrowing costs by a quarter point as weakness in the jobs market overshadows fears that Donald Trump’s tariffs will ...

China is dropping an antitrust probe into Google, as Beijing and Washington step up negotiations over TikTok, Nvidia and trade at a time of heightened tensions between the superpowers.

Australian natural gas developer Santos has defended its growth prospects after Abu Dhabi’s state oil company walked away from an $18.7bn offer, sending shares in the company tumbling.

Roche has agreed to buy drugmaker 89bio in a deal worth up to $3.5bn, the first US acquisition by a Swiss pharmaceuticals group since the Trump administration hit the country with steep tariffs.